XML 54 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Loss Before Income Taxes
Loss before income taxes for the years ended December 31 consisted of the following (in thousands):
202020192018
Domestic$(111,101)$(41,720)$(78,124)
Foreign1,276 1,293 973 
Loss before income taxes$(109,825)$(40,427)$(77,151)
Significant Components of our Provision for Income Taxes
Significant components of our provision for income taxes for the years ended December 31 are as follows (in thousands):
202020192018
Current:
Domestic$— $— $— 
Foreign253 269 249 
Total provision for income taxes$253 $269 $249 
Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate
A reconciliation of the federal statutory income tax rate to the effective income tax rate for the years ended December 31 are as follows (in thousands):
202020192018
Income tax provision at federal statutory rate$(23,063)$(8,490)$(16,202)
Tax on repatriated foreign earnings and other nondeductible items348 403 195 
Section 162(m) limitations5,044 1,438 — 
Change in tax credits3,123 (3,738)(2,148)
Change in valuation allowance21,707 17,842 19,935 
Changes in federal and state tax rates586 (4,058)— 
Stock option exercise (windfall) shortfall(7,683)(1,763)257 
Adjustments to deferred stock compensation3,060 — — 
State and Foreign tax, and other(2,869)(1,365)(1,788)
Total provision for income taxes$253 $269 $249 
Effect of Temporary Differences and Carryforwards
The effect of temporary differences and carryforwards that give rise to deferred tax assets and liabilities for the years ended December 31 were as follows (in thousands):
20202019
Deferred tax assets:
Net operating loss carryforwards$100,927 $73,310 
Research and development tax credit carryforwards9,513 12,636 
Operating lease liability6,962 7,653 
Stock-based compensation5,161 9,680 
Foreign tax credit carryforwards648 633 
Accruals and other8,138 8,219 
Total deferred tax assets before allowance131,349 112,131 
Less: Valuation allowance(114,275)(106,438)
Deferred tax assets, net17,074 5,693 
Deferred tax liabilities:
Debt discount (equity component)12,045 — 
Right of use asset5,029 5,693 
Deferred tax liability17,074 5,693 
Net deferred tax assets and liabilities$— $— 
Summary of Changes in Deferred Tax Asset Valuation Allowance The table below summarizes changes in the deferred tax asset valuation allowance for the years ended December 31 (in thousands):
202020192018
Balance at beginning of year$106,438 $88,596 $68,661 
Charged to costs and expenses8,423 13,784 19,935 
Impact of change in tax rate(586)4,058 — 
Balance at end of year$114,275 $106,438 $88,596 
Total Balance of Unrecognized Gross Tax Benefits Resulting from R&D Credits Claimed
The total balance of unrecognized gross tax benefits for the years ended December 31, resulting from research and development tax credits claimed on the Company’s annual tax return was as follows (in thousands):
202020192018
Unrecognized tax benefits at beginning of year$4,212 $2,830 $2,168 
Additions based on current year tax positions4,959 1,382 662 
Unrecognized tax benefits at end of year$9,171 $4,212 $2,830